These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Species distribution and antimicrobial susceptibility of Burkholderia cepacia complex isolates in clinical infections: Experience from a tertiary care hospital, Southern India. Kumaresan M; Manoharan M; Sugumar M; Sistla S Indian J Med Microbiol; 2024; 49():100613. PubMed ID: 38750965 [TBL] [Abstract][Full Text] [Related]
5. Novel antibiotic combinations proposed for treatment of El-Halfawy OM; Naguib MM; Valvano MA Antimicrob Resist Infect Control; 2017; 6():120. PubMed ID: 29204272 [TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of Burkholderia cepacia complex isolates: Comparison of disk diffusion, Etest®, agar dilution, and broth microdilution methods. Fehlberg LC; Nicoletti AG; Ramos AC; Rodrigues-Costa F; de Matos AP; Girardello R; Marques EA; Gales AC Diagn Microbiol Infect Dis; 2016 Dec; 86(4):422-427. PubMed ID: 27638346 [TBL] [Abstract][Full Text] [Related]
7. Combination antimicrobial susceptibility testing of Burkholderia cepacia complex: significance of species. Abbott FK; Milne KE; Stead DA; Gould IM Int J Antimicrob Agents; 2016 Nov; 48(5):521-527. PubMed ID: 27665523 [TBL] [Abstract][Full Text] [Related]
8. "Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant Zeiser ET; Becka SA; Wilson BM; Barnes MD; LiPuma JJ; Papp-Wallace KM J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167848 [TBL] [Abstract][Full Text] [Related]
9. [Bacteria of the Burkholderia cepacia complex: epidemiology and diagnosis of infection in patients with cystic fibrosis]. Dřevínek P Epidemiol Mikrobiol Imunol; 2014 Feb; 63(1):18-26. PubMed ID: 24730990 [TBL] [Abstract][Full Text] [Related]
10. Major Aspects of Burkholderia gladioli and Burkholderia cepacia Infections in Children. Bedir Demirdag T; Ozkaya Parlakay A; Aygar IS; Gulhan B; Kanik Yuksek S Pediatr Infect Dis J; 2020 May; 39(5):374-378. PubMed ID: 32118858 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of Burkholderia cepacia complex species in cystic fibrosis patients in Argentina during the period 2011-2015. Cipolla L; Rocca F; Martinez C; Aguerre L; Barrios R; Prieto M Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(7):431-434. PubMed ID: 29055510 [TBL] [Abstract][Full Text] [Related]
12. Burkholderia cepacia complex infection in a cohort of Italian patients with cystic fibrosis. Lambiase A; Raia V; Stefani S; Sepe A; Ferri P; Buonpensiero P; Rossano F; Del Pezzo M J Microbiol; 2007 Jun; 45(3):275-9. PubMed ID: 17618236 [TBL] [Abstract][Full Text] [Related]
13. Clinical and microbiological profile of chronic Burkholderia cepacia complex infections in a cystic fibrosis reference hospital in Brazil. da Costa Capizzani CP; Caçador NC; Torres LAGMM; Tonani L; Vandamme P; da Costa Darini AL Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2263-2271. PubMed ID: 28840370 [TBL] [Abstract][Full Text] [Related]
14. Clonality and Antimicrobial Susceptibility of Burkholderia cepacia complex Isolates Collected from Cystic Fibrosis Patients during 1998-2013 in Bern, Switzerland. Lupo A; Isis E; Tinguely R; Endimiani A New Microbiol; 2015 Apr; 38(2):281-8. PubMed ID: 25938755 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis. Zhou J; Chen Y; Tabibi S; Alba L; Garber E; Saiman L Antimicrob Agents Chemother; 2007 Mar; 51(3):1085-8. PubMed ID: 17158942 [TBL] [Abstract][Full Text] [Related]
16. A 17-Year Nationwide Study of Burkholderia cepacia Complex Bloodstream Infections Among Patients in the United States Veterans Health Administration. El Chakhtoura NG; Saade E; Wilson BM; Perez F; Papp-Wallace KM; Bonomo RA Clin Infect Dis; 2017 Oct; 65(8):1253-1259. PubMed ID: 29017247 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of CHROMagar™ B. cepacia agar for the detection of Burkholderia cepacia complex species from sputum samples of patients with cystic fibrosis. Maruri-Aransolo A; de Dios Caballero J; Michelena M; Medina-Pascual MJ; Carrasco G; Asensio O; Cols M; Cantón R; Eur J Clin Microbiol Infect Dis; 2024 Jul; 43(7):1349-1353. PubMed ID: 38780755 [TBL] [Abstract][Full Text] [Related]
18. Exploring the Interplay of Resistance Nodulation Division Efflux Pumps, Gautam V; Kumar S; Patil PP; Meletiadis J; Patil PB; Mouton JW; Sharma M; Daswal A; Singhal L; Ray P; Singh M Microb Drug Resist; 2020 Oct; 26(10):1144-1152. PubMed ID: 32354297 [No Abstract] [Full Text] [Related]
19. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection. Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078 [TBL] [Abstract][Full Text] [Related]
20. Accurate identification and epidemiological characterization of Burkholderia cepacia complex: an update. Devanga Ragupathi NK; Veeraraghavan B Ann Clin Microbiol Antimicrob; 2019 Feb; 18(1):7. PubMed ID: 30717798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]